ACIDE CHLORHYDRIQUE 35% PHARMPUR® Ph Eur x 5L - Atlantic labo ics

CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway

CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway

CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway

CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway

CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway

Acide Chlorhydrique - HCl - Dr Clark - Flacon de 30 ml

CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway

Novel MreB Inhibitors with Antibacterial Activity Against Gram (-) Bacteria

Acide chlorhydrique 35-38% EPR Ph.Eur., Acheter Acide chlorhydrique 35-38% EPR Ph.Eur.

7647-01-0 CAS, HYDROCHLORIC ACID, Acids-Inorganic

Hydrochloric acid 37% AGR ISO - Labbox Export

HClRestriction: Drugs precursors Cat. 3 - AEATM.W: 36.46 CAS: 7647-01-0 EC: 231-595-7 EC INDEX: 017-002-01-X UN: 1789 IMDG: 8 II UN 1789 ADR: 8 II UN

Hydrochloric acid 35-38% EPR